Detalles de la búsqueda
1.
Development and validation of a patient reported experience measure for experimental cancer medicines (PREM-ECM) and their carers (PREM-ECM-Carer).
BMC Cancer
; 24(1): 500, 2024 Apr 19.
Artículo
Inglés
| MEDLINE | ID: mdl-38641809
2.
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
Br J Cancer
; 129(1): 38-45, 2023 07.
Artículo
Inglés
| MEDLINE | ID: mdl-37120671
3.
Patient attrition in Molecular Tumour Boards: a systematic review.
Br J Cancer
; 127(8): 1557-1564, 2022 11.
Artículo
Inglés
| MEDLINE | ID: mdl-35941175
4.
Enrolment of older adults with cancer in early phase clinical trials-an observational study on the experience in the north west of England.
Age Ageing
; 50(5): 1736-1743, 2021 09 11.
Artículo
Inglés
| MEDLINE | ID: mdl-34107012
5.
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer.
Oncologist
; 25(1): 55-63, 2020 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31292268
6.
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
Analyst
; 141(2): 669-78, 2016 Jan 21.
Artículo
Inglés
| MEDLINE | ID: mdl-26605519
7.
Selumetinib in the treatment of non-small-cell lung cancer.
Future Oncol
; 12(22): 2545-2560, 2016 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-27467210
8.
The impact of orthodontic appliances on eating - young people's views and experiences.
J Orthod
; 42(2): 114-22, 2015 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-26118682
9.
Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells.
BMC Genomics
; 15: 1129, 2014 Dec 17.
Artículo
Inglés
| MEDLINE | ID: mdl-25519510
10.
Impact of tumour profiling on clinical trials in salivary gland cancer.
Clin Otolaryngol
; 44(1): 1-6, 2019 01.
Artículo
Inglés
| MEDLINE | ID: mdl-30102009
11.
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials.
Tumori
; : 3008916241248007, 2024 Apr 27.
Artículo
Inglés
| MEDLINE | ID: mdl-38676437
12.
ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
J Natl Cancer Inst
; 2024 May 06.
Artículo
Inglés
| MEDLINE | ID: mdl-38710487
13.
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clin Cancer Res
; 29(2): 331-340, 2023 01 17.
Artículo
Inglés
| MEDLINE | ID: mdl-36378548
14.
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Nat Med
; 29(6): 1400-1411, 2023 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-37277454
15.
Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials.
Cancers (Basel)
; 13(10)2021 May 18.
Artículo
Inglés
| MEDLINE | ID: mdl-34069985
16.
Oncology patients' experiences in experimental medicine cancer trials: a qualitative study.
BMJ Open
; 11(10): e047813, 2021 10 05.
Artículo
Inglés
| MEDLINE | ID: mdl-34610932
17.
Liquid Biopsy in Small Cell Lung Cancer-A Route to Improved Clinical Care?
Cells
; 9(12)2020 12 03.
Artículo
Inglés
| MEDLINE | ID: mdl-33287165
18.
Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants.
Lung Cancer
; 150: 216-220, 2020 12.
Artículo
Inglés
| MEDLINE | ID: mdl-33221678
19.
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.
Nat Cancer
; 1(4): 437-451, 2020 04.
Artículo
Inglés
| MEDLINE | ID: mdl-35121965
20.
Promoting low-flow anaesthesia and volatile anaesthetic agent choice.
BMJ Open Qual
; 8(3): e000479, 2019.
Artículo
Inglés
| MEDLINE | ID: mdl-31637316